Substandard manufacturing can introduce truncated peptide sequences, residual solvents, or bacterial endotoxins that compromise experimental data
Previous studies have established that bile acids stimulate the release of GLP-1 from enteroendocrine cells, both in vivo and in vitro (Katsuma et al., 2+ pathway
Individuals can stay motivated and sustain long-term success by monitoring weight, body measurements, food intake, physical activity, and other health markers
GLP-1 medications, including semaglutide and tirzepatide are not currently approved for the treatment of endometriosis by the Medicines & Healthcare products Regulatory Agency or the Food & Drug Administration
PrecisionLifes platform applies mechanistic patient stratification, identifying the specific combinations of genetic and biological drivers that create different subgroups within a disease
Emerging data suggests a majority of obese PCOS patients who had not responded to lifestyle changes alone achieved significant weight loss once semaglutide was added to their treatment plan